Hammersmith Hospital
London, W12 0NN, United Kingdom
NCT Number: NCT00147030
Hypothesis: Prolonged whole body cooling in term infants with perinatal asphyxial encephalopathy reduces death and severe neurodevelopmental disability.
This study aims to determine whether whole body cooling to 33-34°C is a safe treatment that improves survival, without severe neurological or neurodevelopmental impairments at 18 months, of term infants suffering perinatal asphyxial encephalopathy.
Looking for future studies?
Notify Me1 hour–6 hour
All sexes
Interventional
Not applicable
London, W12 0NN, United Kingdom
This is a multicentre prospective randomised controlled trial to determine whether a reduction of body temperature by 3-4°C following perinatal asphyxia improves survival without neurodevelopmental disability.
Full term infants will be randomised within 6 hours of birth to either a control group with the rectal temperature kept at 37 ± 0.2°C or to whole body cooling with the rectal temperature kept at 33.5 ± 0.5°C for 72 hours followed by slow rewarming.
The outcome will be assessed at 18 months of age by survival and neurological and neurodevelopmental testing.
Eligibility criteria:
Term infants less than 6 hours after birth with moderate or severe perinatal asphyxia (a combination of clinical and EEG criteria).
Exclusion criteria
Infants expected to be 6 hours of age at the time of randomisation or infants with major congenital abnormalities.
Intervention:
Intensive care with whole body cooling versus intensive care without whole body cooling (babies are cooled to 33.5°C for 72 hours)
Main Outcomes:
Death and severe neurodevelopmental impairment at 18 months of age
Secondary Outcomes:
Cerebral thrombosis or haemorrhage, persistent hypotension, pulmonary hypertension, abnormal coagulation, arrhythmia and sepsis in the neonatal period. Neurological impairments at 18 months
Number of patients required: 236.
On 30th November 2006, when recruitment closed, 325 babies had been recruited.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
The infant will be assessed sequentially by criteria A, B and C listed below:
A. Infants =>36 completed weeks gestation admitted to the Neonatal Intensive Care Unit (NICU) with at least one of the following:
Infants that meet criteria A will be assessed for whether they meet the neurological abnormality entry criteria (B) by trained personnel:
B. Moderate to severe encephalopathy, consisting of altered state of consciousness (lethargy, stupor or coma) AND at least one of the following:
Infants that meet criteria A & B will be assessed by amplitude-integrated electroencephalogram (aEEG) (read by trained personnel):
C. At least 30 minutes duration of amplitude integrated EEG recording that shows abnormal background aEEG activity or seizures. There must be one of the following:
Exclusion criteria
Target rectal temperature 33-34°C for 72 hours, commencing by 6 hours of age; followed by re-warming at 0.5°C to normothermia
Time frame: 18 months
Severe neurodevelopmental disability was defined as a score of less than 70 on the Mental Developmental Index of the Bayley Scales of Infant Development II (BSID-II) (on which the standardization mean [± standard deviation (SD)] is 100±15 and higher scores indicate better performance), a score of 3 to 5 on the Gross Motor Function Classification System (GMFCS) (on which scores can range from 1 to 5, with higher scores indicating greater impairment), or bilateral cortical visual impairment with no useful vision.
Time frame: Duration of hospital stay, on average 22 days
Intracranial hemorrhage was identified on magnetic resonance imaging (MRI).
Time frame: Duration of hospital stay, on average 22 days
Hypotension was defined as a mean blood pressure of 40 mm Hg or less and was persistent if causes of hypotension had been sought and appropriate treatment provided, without success.
Time frame: Duration of hospital stay, on average 22 days
Time frame: Duration of hospital stay, on average 22 days
Time frame: Duration of hospital stay, on average 22 days
Time frame: Duration of hospital stay, on average 22 days
Time frame: Duration of hospital stay, on average 22 days
Time frame: Duration of hospital stay, on average 22 days
Arrhythmia identified on electrocardiogram (ECG), e.g. sinus bradycardia <80 beats per minute, ventricular arrhythmia.
Time frame: Duration of hospital stay, on average 22 days
Time frame: Duration of hospital stay, on average 22 days
Time frame: Duration of hospital stay, on average 22 days
Time frame: Before discharge from hospital
Time frame: Duration of hospital stay, on average 22 days
Time frame: Duration of hospital stay, on average 22 days
Total duration of hospital care
Time frame: 18 months
Time frame: 18 months
Time frame: 18 months
defined as the presence of any two of the following in an infant; neuromotor disability (Level 3-5 on Gross Motor Function classification), mental delay (Bayley Mental Developmental Index (MDI) score < 70), epilepsy, cortical visual impairment, sensorineural hearing loss
Time frame: 18 months
Bayley Psychomotor Developmental Index score (PDI) <70
Time frame: 18 months
Normal or near normal hearing, no sensorineural hearing loss
Time frame: 18 months
Time frame: 18 months
Head circumference at follow-up >2 standard deviations below the mean
Imperial College London
Other
Whole Body Hypothermia for the Treatment of Perinatal Asphyxial Encephalopathy
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03278847
Asphyxia Neonatorum, Body Temperature Changes
London, United Kingdom
View Trial DetailsNCT03177980
Agnosia, Asphyxia
Lund, Sweden
View Trial DetailsNCT07681960
Airway Management, Asphyxia Neonatorum
Kahramanmaraş, Turkey (Türkiye)
View Trial DetailsNCT05349175
Asphyxia Neonatorum, Birth Asphyxia
Boston, Massachusetts, United States
View Trial Details